ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,331,960 | -4.2% | 124,003 | +27.1% | 0.00% | 0.0% |
Q2 2023 | $3,477,920 | +81.4% | 97,530 | +29.2% | 0.00% | 0.0% |
Q1 2023 | $1,917,623 | +70.5% | 75,497 | +206.9% | 0.00% | 0.0% |
Q4 2022 | $1,124,932 | -13.5% | 24,600 | -32.1% | 0.00% | 0.0% |
Q3 2022 | $1,300,000 | -54.9% | 36,208 | -54.0% | 0.00% | 0.0% |
Q2 2022 | $2,884,000 | -60.6% | 78,778 | -50.5% | 0.00% | -50.0% |
Q1 2022 | $7,314,000 | -44.4% | 159,051 | -19.9% | 0.00% | -33.3% |
Q4 2021 | $13,159,000 | +0.9% | 198,463 | -5.0% | 0.00% | -25.0% |
Q3 2021 | $13,037,000 | -35.0% | 208,812 | -13.7% | 0.00% | -55.6% |
Q2 2021 | $20,043,000 | +78.4% | 242,004 | +42.9% | 0.01% | +50.0% |
Q1 2021 | $11,232,000 | -49.2% | 169,387 | -41.3% | 0.01% | -50.0% |
Q4 2020 | $22,131,000 | +88.1% | 288,421 | +5.6% | 0.01% | +71.4% |
Q3 2020 | $11,764,000 | -11.2% | 273,198 | -10.9% | 0.01% | -30.0% |
Q2 2020 | $13,242,000 | +422.8% | 306,607 | +248.1% | 0.01% | +233.3% |
Q1 2020 | $2,533,000 | -74.0% | 88,081 | -42.6% | 0.00% | -78.6% |
Q4 2019 | $9,734,000 | +1450.0% | 153,461 | +588.8% | 0.01% | +1300.0% |
Q3 2019 | $628,000 | -25.7% | 22,280 | -51.6% | 0.00% | 0.0% |
Q1 2019 | $845,000 | +314.2% | 46,052 | +181.1% | 0.00% | – |
Q4 2018 | $204,000 | -69.9% | 16,385 | -67.1% | 0.00% | -100.0% |
Q2 2018 | $677,000 | +420.8% | 49,779 | +41.0% | 0.00% | – |
Q4 2017 | $130,000 | – | 35,299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |